References
- Abdul-Ghani MA, DeFronzo RA. (2010). Pathogenesis of insulin resistance in skeletal muscle. J Biomed Biotechnol, 2010, 476279.
- Allick G, Sprangers F, Weverling GJ, Ackermans MT, Meijer AJ, Romijn JA, Endert E, Bisschop PH, Sauerwein HP. (2004). Free fatty acids increase hepatic glycogen content in obese males. Metab Clin Exp, 53, 886–893.
- Chang AM, Smith MJ, Galecki AT, Bloem CJ, Halter JB. (2006). Impaired beta-cell function in human aging: Response to nicotinic acid-induced insulin resistance. J Clin Endocrinol Metab, 91, 3303–3309.
- Chang MC, Pralle A, Isacoff EY, Chang CJ. (2004). A selective, cell-permeable optical probe for hydrogen peroxide in living cells. J Am Chem Soc, 126, 15392–15393.
- Chen L, Magliano DJ, Zimmet PZ. (2012). The worldwide epidemiology of type 2 diabetes mellitus–present and future perspectives. Nat Rev Endocrinol, 8, 228–236.
- Ginsberg HN. (2006). Niacin in the metabolic syndrome: More risk than benefit? Nat Clin Pract Endocrinol Metab, 2, 300–301.
- Greenbaum CJ, Kahn SE, Palmer JP. (1996). Nicotinamide’s effects on glucose metabolism in subjects at risk for IDDM. Diabetes, 45, 1631–1634.
- Henriksen EJ, Diamond-Stanic MK, Marchionne EM. (2011). Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radic Biol Med, 51, 993–999.
- Houstis N, Rosen ED, Lander ES. (2006). Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature, 440, 944–948.
- Institute of Medicine. (1998). Niacin. In: Food and Nutrition Board, ed. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academy Press, 123–149.
- Kahn SE, Beard JC, Schwartz MW, Ward WK, Ding HL, Bergman RN, Taborsky GJ Jr, Porte D Jr. (1989). Increased beta-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance. Diabetes, 38, 562–568.
- Knip M, Douek IF, Moore WP, Gillmor HA, McLean AE, Bingley PJ, Gale EA; European Nicotinamide Diabetes Intervention Trial Group. (2000). Safety of high-dose nicotinamide: A review. Diabetologia, 43, 1337–1345.
- Li D, Sun WP, Zhou YM, Liu QG, Zhou SS, Luo N, Bian FN, Zhao ZG, Guo M. (2010). Chronic niacin overload may be involved in the increased prevalence of obesity in US children. World J Gastroenterol, 16, 2378–2387.
- Menon RM, González MA, Adams MH, Tolbert DS, Leu JH, Cefali EA. (2007). Effect of the rate of niacin administration on the plasma and urine pharmacokinetics of niacin and its metabolites. J Clin Pharmacol, 47, 681–688.
- Sun WP, Li D, Lun YZ, Gong XJ, Sun SX, Guo M, Jing LX, Zhang LB, Xiao FC, Zhou SS. (2012). Excess nicotinamide inhibits methylation-mediated degradation of catecholamines in normotensives and hypertensives. Hypertens Res, 35, 180–185.
- Swinburn BA, Sacks G, Hall KD, McPherson K, Finegood DT, Moodie ML, Gortmaker SL. (2011). The global obesity pandemic: Shaped by global drivers and local environments. Lancet, 378, 804–814.
- Zhou SS, Li D, Sun WP, Guo M, Lun YZ, Zhou YM, Xiao FC, Jing LX, Sun SX, Zhang LB, Luo N, Bian FN, Zou W, Dong LB, Zhao ZG, Li SF, Gong XJ, Yu ZG, Sun CB, Zheng CL, Jiang DJ, Li ZN. (2009). Nicotinamide overload may play a role in the development of type 2 diabetes. World J Gastroenterol, 15, 5674–5684.
- Zhou SS, Li D, Zhou YM, Sun WP, Liu QG. (2010). B-Vitamin consumption and the prevalence of diabetes and obesity among the US adults: Population based ecological study. BMC Public Health, 10, 746.
- Zhou SS, Zhou YM, Li D, Lun YZ. (2011). Dietary methyl-consuming compounds and metabolic syndrome. Hypertens Res, 34, 1239–1245.